Half Year 2019 Verona Pharma PLC Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Second Quarter 2019 Verona Pharma Earnings Conference Call. (Operator Instructions) I would now like to turn the conference over to your host, Ms. Stephanie Carrington, Investor Relations. You may begin.
Thank you, operator. Good morning or afternoon, depending on where you are, and welcome to today's call to review Verona Pharma's results for the 3 and 6 months ended June 30, 2019.
On this call, I am joined by Jan-Anders Karlsson, Chief Executive Officer; and Piers Morgan, Chief Financial Officer. I trust you have seen the press release that was -- that included the results for the 3 and 6 months ended June 30, 2019, as well as the operational update and the press release with the data from the Phase II study with a dry powder inhaler formulation of ensifentrine.
If you have not, the press releases are also available on the Investor Relations portion of Verona Pharma's website. A slide presentation related to the DPI Phase II trial data has been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
